The Technical Analyst
Select Language :
Aeglea Bio Therapeutics [AGLE]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Aeglea Bio Therapeutics Price, Forecast, Insider, Ratings, Fundamentals & Signals

Aeglea Bio Therapeutics is listed at the  Exchange

6.66% $12.01

America/New_York / 27 nov 2023 @ 16:00


Aeglea Bio Therapeutics: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 48.63 mill
EPS: -74.15
P/E: -0.162
Earnings Date: Mar 04, 2024
SharesOutstanding: 4.05 mill
Avg Daily Volume: 0.0595 mill
RATING 2023-12-26
B
Neutral
RATINGS
Rating CashFlow: Buy
Return On Equity: Strong Buy
Return On Asset: Sell
DE: Sell
P/E: Sell
Price To Book: Strong Sell
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.162 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.03x
Company: PE -0.162 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 16.91 - 21.69

( +/- 12.36%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-12-29 Fairmount Funds Management Llc Buy 406 038 Common Stock
2023-12-29 Fairmount Funds Management Llc Sell 3 435 480 Common Stock
2023-12-22 Burrows Scott L Buy 134 953 Common Stock
2023-12-07 Fairmount Funds Management Llc Buy 16 667 Series B Preferred Stock
2023-11-22 Albers Jeffrey W. Buy 50 000 Stock Option (Right to Buy)
INSIDER POWER
-5.37
Last 85 transactions
Buy: 64 136 392 | Sell: 71 129 759

Forecast: 01:40 - $14.89

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $12.01 (6.66% )
Volume 0.0432 mill
Avg. Vol. 0.0595 mill
% of Avg. Vol 72.62 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Aeglea Bio Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Aeglea Bio Therapeutics Inc

RSI

Intraday RSI14 chart for Aeglea Bio Therapeutics Inc

Last 10 Buy & Sell Signals For AGLE

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Aeglea Bio Therapeutics Inc

AGLE

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. It also develops AGLE-177, a polyethylene glycol modified, which is in Phase I/II clinical trial for the treatment of patient with homocystinuria. In addition, the company's preclinical pipeline includes AGLE-325 for the treatment of cystinuria, as well as other research programs. The company was formerly known as Aeglea BioTherapeutics Holdings, LLC and changed its name to Aeglea BioTherapeutics, Inc. in March 2015. Aeglea BioTherapeutics, Inc. was founded in 2013 and is headquartered in Austin, Texas.

Last 10 Buy Signals

Date Signal @
PENDLEUSDMar 28 - 07:284.12
KCSUSDMar 28 - 07:19$12.09
DIGGUSDMar 28 - 07:19914.30
ETHXUSDMar 28 - 07:183 584.83
CTXUSDMar 28 - 07:194.55
TETUSDMar 28 - 07:1328.60
RUNEUSDMar 28 - 07:15$9.38
HTUSDMar 28 - 07:14$0.850
^AEXMar 28 - 07:00PTS881.83
PROPCUSDMar 28 - 07:084.91

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.